ONTARGET study of telmisartan, ramipril, or both in high-risk patients

被引：1
|
作者：
Ram, C. Venkata S.
机构：
来源：
CURRENT HYPERTENSION REPORTS | 2008年 / 10卷 / 05期
关键词：
D O I：
10.1007/s11906-008-0065-3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：345 / 348
页数：4
相关论文
共 50 条
  • [1] ONTARGET study of telmisartan, ramipril, or both in high-risk patients
    C. Venkata S. Ram
    [J]. Current Hypertension Reports, 2008, 10 : 345 - 348
  • [2] Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data
    Yu Li-tian
    Zhu Jun
    Tan Hui-qiong
    Wang Guo-gan
    Teo, Koon K.
    Liu Li-sheng
    [J]. CHINESE MEDICAL JOURNAL, 2011, 124 (12) : 1763 - 1768
  • [3] Review of ONTARGET: Treating Patients at High Risk for Vascular Events with Telmisartan, Ramipril, or Both
    Guthrie, Robert M.
    [J]. POSTGRADUATE MEDICINE, 2009, 121 (02) : 202 - 204
  • [4] ONTARGET: Use of ramipril, telmisartan, or both in patients with high cardiovascular risks
    HoWon Lee
    Amgad N. Makaryus
    Samy I. McFarlane
    [J]. Current Diabetes Reports, 2009, 9 (3) : 185 - 187
  • [5] Telmisartan, Ramipril, or both in patients at high risk for vascular events. Results of the ONTARGET trial
    Lyakishev, A. A.
    [J]. KARDIOLOGIYA, 2008, 48 (05) : 72 - 72
  • [6] Telmisartan is as affective as ramipril in preventing cardiovascular events in high-risk patients, but no additional protective benefit was achieved if ramipril and telmisartan are combined - ONTARGET trial
    不详
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (07): : 604 - 605
  • [7] A comparison of efficacy of telmisartan and ramipril alone or in combination in reduction of cardiovascular events in high-risk patients - results from the ONTARGET study
    Szczepaniak-Chichel, Ludwina
    [J]. ARTERIAL HYPERTENSION, 2008, 12 (02): : 140 - 147
  • [8] Telmisartan, ramipril, or both in patients at high risk for vascular events
    Vidt, Donald G.
    [J]. CURRENT HYPERTENSION REPORTS, 2008, 10 (05) : 343 - 344
  • [9] Telmisartan, ramipril, or both in patients at high risk for vascular events
    Dominiak, Marcin
    [J]. KARDIOLOGIA POLSKA, 2008, 66 (06) : 705 - 707
  • [10] Telmisartan, ramipril, or both in patients at high risk for vascular events
    Yusuf, Salim
    Teo, Koon K.
    Pogue, Janice
    Dyal, Leanne
    Copland, Ingrid
    Schumacher, Helmut
    Ingelheim, Boehringer
    Dagenais, Gilles
    Sleight, Peter
    Anderson, Craig
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15): : 1547 - 1559
12345